Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics
暂无分享,去创建一个
[1] R. Branch,et al. Effects of age and cigarette smoking on propranolol disposition , 1979, Clinical pharmacology and therapeutics.
[2] R. Branch,et al. The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration , 1978, Clinical pharmacokinetics.
[3] J. LeLorier,et al. Bioavailabllity of lidocaine in normal volunteers and cirrhotic patients , 1978 .
[4] Jerome J. Schentag,et al. Enhanced biotransformation of theophylline in marihuana and tobacco smokers , 1978, Clinical pharmacology and therapeutics.
[5] W. Parsons,et al. Effect of smoking on caffeine clearance , 1978, Clinical pharmacology and therapeutics.
[6] R. Branch,et al. Biological determinants of propranolol disposition in man , 1978, Clinical pharmacology and therapeutics.
[7] A. Conney,et al. Phenacetin metabolism: Effect of hydrocarbons and cigarette smoking , 1977, Clinical pharmacology and therapeutics.
[8] Y. Latour,et al. GLC determination of lidocaine in human plasma. , 1977, Journal of pharmaceutical sciences.
[9] J. Boyer,et al. Chronic hepatitis--a perspective on classification and determinants of prognosis. , 1976, Gastroenterology.
[10] R. Gugler,et al. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect. , 1975, The Journal of pharmacology and experimental therapeutics.
[11] Grant R. Wilkinson,et al. A physiological approach to hepatic drug clearance , 1975 .
[12] H. Nagasawa,et al. Decreased theophylline half-life in cigarette smokers. , 1975, Life sciences.
[13] M. Gibaldi,et al. Clearance and biologic half-life as indices of intrinsic hepatic metabolism. , 1974, The Journal of pharmacology and experimental therapeutics.
[14] C. Swett. Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program. , 1974, Archives of general psychiatry.
[15] T. Reynolds. The role of hemodynamic measurements in portosystemic shunt surgery. , 1974, Archives of surgery.
[16] M. Gerber,et al. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. , 1973, Archives of pathology.
[17] W. Steinbrunn,et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. , 1973, Annals of internal medicine.
[18] R. Boyes,et al. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. , 1972, The Journal of pharmacology and experimental therapeutics.
[19] M Gibaldi,et al. Influence of first-pass effect on availability of drugs on oral administration. , 1971, Journal of pharmaceutical sciences.
[20] K. Melmon,et al. DISPOSITION KINETICS OF LIDOCAINE IN NORMAL SUBJECTS * , 1971, Annals of the New York Academy of Sciences.
[21] John F. Williams,et al. Hemodynamic Effects of Lidocaine in Patients with Heart Disease , 1968, Circulation.
[22] S. Shaldon,et al. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. , 1961, Clinical science.
[23] D. Pessayre,et al. Mechanism for reduced drug clearance in patients with cirrhosis. , 1978, Gastroenterology.
[24] P. Huet,et al. Extraction of 125I-albumin microaggregates from portal blood. An index of functional portal blood supply in cirrhotics. , 1976, Gastroenterology.
[25] D. Shand,et al. Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate. , 1973, American heart journal.
[26] D. Shand,et al. The disposition of propranolol. I. Elimination during oral absorption in man. , 1972, Pharmacology.
[27] M. Rowland,et al. Influence of route of administration on drug availability. , 1972, Journal of pharmaceutical sciences.
[28] S. Riegelman,et al. Influence of the route of administration on the area under the plasma concentration-time curve. , 1969, Journal of pharmaceutical sciences.
[29] E. Plater. [Hepatic clearance]. , 1961, Archivos argentinos de pediatria.